Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

Alyssa C. Fears, William B. Klimstra, Paul Duprex, Amy Hartman, Scott C. Weaver, Kenneth S. Plante, Divya Mirchandani, Jessica Ann Plante, Patricia V. Aguilar, Diana Fernández, Aysegul Nalca, Aysegul Totura, David Dyer, Brian Kearney, Matthew Lackemeyer, J. Kyle Bohannon, Reed Johnson, Robert F. Garry, Doug S. Reed, Chad J. Roy

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome. Although we performed experiment only once across several laboratories, our findings suggest retained infectivity and virion integrity for up to 16 hours in respirable-sized aerosols.

Original languageEnglish (US)
JournalEmerging infectious diseases
Volume26
Issue number9
DOIs
StatePublished - Sep 1 2020

Keywords

  • 2019 novel coronavirus disease
  • COVID-19
  • MERS-CoV
  • Middle East respiratory syndrome coronavirus
  • SARS-CoV
  • SARS-CoV-2
  • aerosol
  • coronavirus diseases
  • respiratory diseases
  • severe acute respiratory syndrome coronavirus
  • severe acute respiratory syndrome coronavirus 2
  • viruses
  • zoonoses

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions'. Together they form a unique fingerprint.

Cite this